India Glycols Ltd Valuation Shifts to Fair Amidst Strong Market Performance

Valuation Metrics and Recent Changes

As of 28 April 2026, India Glycols trades at a price of ₹967.75, slightly up 0.44% from the previous close of ₹963.50. The stock’s 52-week range spans from ₹502.50 to ₹1,222.85, indicating significant volatility over the past year. The company’s price-to-earnings (P/E) ratio currently stands at 24.05, while the price-to-book value (P/BV) is 2.72. These figures have contributed to the recent downgrade in valuation grade from attractive to fair, signalling a more cautious stance among investors.

The enterprise value to EBITDA (EV/EBITDA) ratio is 13.46, and the EV to EBIT ratio is 17.56, both metrics suggesting a moderate premium relative to earnings. The PEG ratio, which adjusts the P/E for earnings growth, is 1.23, indicating that the stock is fairly valued when growth prospects are considered. Dividend yield remains modest at 1.25%, while return on capital employed (ROCE) and return on equity (ROE) are 10.20% and 10.83% respectively, reflecting steady operational efficiency and shareholder returns.

Comparative Analysis with Industry Peers

When benchmarked against its peers in the commodity chemicals sector, India Glycols’ valuation appears more reasonable. Several competitors are trading at significantly higher multiples, with Navin Fluorine International commanding a P/E of 60.06 and an EV/EBITDA of 36.26, categorised as very expensive. Himadri Speciality Chemical and Acutaas Chemical also trade at elevated valuations, with P/E ratios of 38.32 and 71.18 respectively.

Other notable peers such as Deepak Nitrite and Atul Chemicals are classified as expensive, with P/E ratios of 42.29 and 29.09. Even Supreme Petrochemicals, which shares a fair valuation grade, trades at a higher P/E of 42.97 compared to India Glycols. This relative affordability could appeal to investors seeking exposure to the sector without the premium price tags.

Stock Performance Relative to Sensex

India Glycols has delivered impressive returns over multiple time horizons, significantly outperforming the benchmark Sensex. Over the past one year, the stock has surged 36.40%, while the Sensex declined by 2.41%. The three-year and five-year returns are even more striking, with India Glycols appreciating 248.52% and 306.79% respectively, compared to Sensex gains of 27.46% and 57.94% over the same periods.

Even on a decade-long basis, the stock’s return of 2,096.94% dwarfs the Sensex’s 196.59%, underscoring the company’s long-term growth trajectory. Shorter-term returns also reflect positive momentum, with a 9.16% gain over the past month versus a 5.06% rise in the Sensex, and a 0.43% increase in the last week compared to a 1.55% decline in the benchmark.

Implications of Valuation Grade Change

The shift from an attractive to a fair valuation grade, as recorded on 24 April 2026, signals a recalibration of investor expectations. While the company’s fundamentals remain solid, the market appears to be pricing in a more tempered growth outlook or factoring in sector-wide risks. The Mojo Score of 54.0 and a Hold grade reflect this balanced view, upgraded from a previous Sell rating, indicating cautious optimism.

India Glycols’ small-cap status also plays a role in valuation dynamics, as smaller companies often experience greater volatility and liquidity constraints. The current valuation metrics suggest that while the stock is no longer a bargain, it remains reasonably priced relative to its earnings and growth potential, especially when compared to its more richly valued peers.

Outlook and Investor Considerations

Investors analysing India Glycols should weigh the company’s robust historical performance and reasonable valuation against sector volatility and competitive pressures. The commodity chemicals industry is subject to cyclical demand and raw material price fluctuations, which can impact margins and earnings visibility.

Given the current P/E of 24.05 and P/BV of 2.72, the stock is fairly valued but no longer offers the deep discount it once did. The EV/EBITDA multiple of 13.46 is moderate compared to peers, suggesting that the market is assigning a balanced premium for operational efficiency and growth prospects.

Return ratios such as ROCE and ROE hovering around 10% indicate steady but not exceptional capital efficiency, which may temper expectations for rapid re-rating. The modest dividend yield of 1.25% adds some income appeal but is unlikely to be a primary driver for investors.

Overall, India Glycols presents a compelling case for investors seeking exposure to the commodity chemicals sector at a fair valuation, especially when contrasted with the very expensive multiples of many peers. However, the recent downgrade in valuation grade advises a prudent approach, favouring a Hold stance until clearer catalysts emerge.

Conclusion

India Glycols Ltd’s transition from an attractive to a fair valuation grade reflects evolving market sentiment amid strong historical returns and a competitive peer environment. While the stock remains reasonably priced relative to earnings and growth, investors should remain mindful of sector risks and valuation pressures. The company’s solid fundamentals and outperformance versus the Sensex provide a foundation for cautious optimism, but the Hold rating suggests waiting for further clarity before committing additional capital.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →